Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Obinutuzumab in Combination With High-Dose Methylprednisolone in Chronic Lymphocytic Leukemia Patients

NCT02229422 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT02229422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02229422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Obinutuzumab in Combination With High-Dose Methylprednisolone in Chronic Lymphocytic Leukemia Patients
Lead sponsor
University of California, San Diego
Phase
Phase 1/2
Overall status
Unknown status
Start date
September 30, 2014
Completion date
December 25, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cll